Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
about
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerExpression of RFC/SLC19A1 is associated with tumor type in bladder cancer patients.Expression of NRG1 and its receptors in human bladder cancer.Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.ERBB4 is over-expressed in human colon cancer and enhances cellular transformationUrothelial tumorigenesis: a tale of divergent pathways.Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivoThe relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patientsDirecting HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.ErbB3 is required for ductal morphogenesis in the mouse mammary gland.Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrantNeuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.Clinical applications of mouse models for breast cancer engaging HER2/neu.Potential of ErbB4 antibodies for cancer therapy.Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed.Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells.The epidermal growth factor family has a dual role in deciding the fate of cancer cells.Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.Heregulin-alpha and heregulin-beta expression is linked to a COX-2-PGE2 pathway in human gastric fibroblasts.Prognostic significance of HER3 in patients with malignant solid tumors.Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance.Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients.Soluble HER3 predicts survival in bladder cancer patients.The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.
P2860
Q33554443-1548EB14-D895-4FD9-BD4E-582B93EAA2DCQ33961547-0887D87E-232A-457E-BB2A-DC33B9A92663Q34745805-8CB73CF1-9FE8-49AC-862B-2E90F584D1D4Q35146683-8D84DB75-9D05-4E6B-8CB4-AE4DC1A54B9CQ36067899-F3FD5C6A-9B83-4B23-9F09-C498655C627AQ36234720-E41CDDA5-014D-415A-8FB9-9DDC798ABD50Q36408020-851AB265-9931-4A5D-9C56-651B6314A9BCQ36614287-C79309D0-6393-4CF2-AC44-7D3476FD426BQ36924803-EF4D92AF-0E9F-417E-AF86-6D0ABE6BFFEBQ37021760-652B19DE-DB17-48AD-8A64-47B3E0000205Q37131318-2F502FFE-0B19-4B09-9E9A-C2256C4057E0Q37393002-4B677A9B-10FE-49A3-A1ED-776BE329B621Q37564335-FC51B436-94B2-4860-848D-535FF95A57F1Q37607675-09590378-6ED2-45E9-8D85-0283B3A5616AQ37658764-99E20654-0971-4345-871D-FA9C818994CAQ37727542-39BF61D3-6329-43D8-AB68-1E77913D30F0Q37933675-CB9F9017-6DF5-4794-8164-F84A52B74968Q38787643-32049257-FD24-49C9-8088-BFDC7A72B92BQ39098404-E5A3C7B1-4A4B-434D-9BE8-D05499D05048Q39499017-5B4BFE25-5B85-4C40-9079-1A91965DE00FQ39687374-6C2816BD-A916-43C1-9C2B-703D6BDF661BQ40209050-6F6C737B-C813-4718-BF67-D3A63886DAD0Q40210754-C6ADC372-AEFB-423E-A020-1539D2676251Q40339674-1A7DFD54-55B7-442F-92DD-CE54C23D1D5FQ42148898-9F2C7115-3C2D-46CD-938B-01B871BED057Q45899687-3B8EEBF6-BF61-4EC5-AD10-EB092E25BFEFQ46215779-F462C9A3-289A-4000-8C55-D39658AE1579Q47948456-98048526-5540-4CDB-A678-3D927E1FDC4DQ49693939-70098F1F-D65D-4B3B-9F85-493E8A5E0A3BQ50182629-8DAD5EF6-2758-461C-A84B-BC51FE8AF084Q51051063-E8211100-5760-4306-953A-0A4315581493
P2860
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@ast
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@en
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@nl
type
label
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@ast
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@en
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@nl
prefLabel
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@ast
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@en
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@nl
P2093
P2860
P3181
P356
P1476
Expression of HER3, HER4 and t ...... val in bladder cancer patients
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6602251
P407
P577
2004-12-13T00:00:00Z
P5875
P6179
1020886894